WO2023187632A1 - Composition, application of the composition, cosmetic preparation hydrogel bio-mask in the form of a compress, method of manufacturing the preparation - Google Patents
Composition, application of the composition, cosmetic preparation hydrogel bio-mask in the form of a compress, method of manufacturing the preparation Download PDFInfo
- Publication number
- WO2023187632A1 WO2023187632A1 PCT/IB2023/053056 IB2023053056W WO2023187632A1 WO 2023187632 A1 WO2023187632 A1 WO 2023187632A1 IB 2023053056 W IB2023053056 W IB 2023053056W WO 2023187632 A1 WO2023187632 A1 WO 2023187632A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hydrolate
- weight
- parts
- amount
- component
- Prior art date
Links
- 239000000017 hydrogel Substances 0.000 title claims abstract description 131
- 239000000203 mixture Substances 0.000 title claims abstract description 105
- 239000002537 cosmetic Substances 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 12
- 239000003921 oil Substances 0.000 claims abstract description 62
- SEBFKMXJBCUCAI-UHFFFAOYSA-N NSC 227190 Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC=C(C=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-UHFFFAOYSA-N 0.000 claims abstract description 57
- SEBFKMXJBCUCAI-HKTJVKLFSA-N silibinin Chemical compound C1=C(O)C(OC)=CC([C@@H]2[C@H](OC3=CC=C(C=C3O2)[C@@H]2[C@H](C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 SEBFKMXJBCUCAI-HKTJVKLFSA-N 0.000 claims abstract description 54
- 229960004245 silymarin Drugs 0.000 claims abstract description 53
- 235000017700 silymarin Nutrition 0.000 claims abstract description 53
- 240000002900 Arthrospira platensis Species 0.000 claims abstract description 42
- 229940082787 spirulina Drugs 0.000 claims abstract description 42
- 235000016425 Arthrospira platensis Nutrition 0.000 claims abstract description 41
- 241000199919 Phaeophyceae Species 0.000 claims abstract description 34
- 239000004480 active ingredient Substances 0.000 claims abstract description 34
- LFYJSSARVMHQJB-UHFFFAOYSA-N Backuchiol Natural products CC(C)=CCCC(C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-UHFFFAOYSA-N 0.000 claims abstract description 32
- LFYJSSARVMHQJB-GOSISDBHSA-N bakuchinol Natural products CC(C)=CCC[C@@](C)(C=C)C=CC1=CC=C(O)C=C1 LFYJSSARVMHQJB-GOSISDBHSA-N 0.000 claims abstract description 32
- LFYJSSARVMHQJB-QIXNEVBVSA-N bakuchiol Chemical compound CC(C)=CCC[C@@](C)(C=C)\C=C\C1=CC=C(O)C=C1 LFYJSSARVMHQJB-QIXNEVBVSA-N 0.000 claims abstract description 32
- 229940117895 bakuchiol Drugs 0.000 claims abstract description 32
- KXXXNMZPAJTCQY-UHFFFAOYSA-N bakuchiol Natural products CC(C)CCCC(C)(C=C)C=Cc1ccc(O)cc1 KXXXNMZPAJTCQY-UHFFFAOYSA-N 0.000 claims abstract description 32
- 239000011159 matrix material Substances 0.000 claims abstract description 27
- 244000178870 Lavandula angustifolia Species 0.000 claims abstract description 17
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims abstract description 16
- 239000001102 lavandula vera Substances 0.000 claims abstract description 16
- 235000018219 lavender Nutrition 0.000 claims abstract description 16
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 16
- 230000003385 bacteriostatic effect Effects 0.000 claims abstract description 14
- 239000004615 ingredient Substances 0.000 claims abstract description 14
- 235000010443 alginic acid Nutrition 0.000 claims abstract description 13
- 229920000615 alginic acid Polymers 0.000 claims abstract description 13
- 230000002421 anti-septic effect Effects 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 8
- 230000001172 regenerating effect Effects 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 89
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 75
- 235000019198 oils Nutrition 0.000 claims description 61
- 229920000642 polymer Polymers 0.000 claims description 52
- 238000006243 chemical reaction Methods 0.000 claims description 47
- 235000010413 sodium alginate Nutrition 0.000 claims description 43
- 239000011541 reaction mixture Substances 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 35
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 33
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 31
- 238000004132 cross linking Methods 0.000 claims description 30
- 239000003431 cross linking reagent Substances 0.000 claims description 29
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 25
- 238000003756 stirring Methods 0.000 claims description 25
- 239000012153 distilled water Substances 0.000 claims description 23
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 22
- 235000004496 Oenothera biennis Nutrition 0.000 claims description 21
- 235000021324 borage oil Nutrition 0.000 claims description 18
- 150000002632 lipids Chemical class 0.000 claims description 18
- 235000001466 Ribes nigrum Nutrition 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 15
- 239000000661 sodium alginate Substances 0.000 claims description 15
- 229940005550 sodium alginate Drugs 0.000 claims description 15
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims description 14
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 claims description 14
- 235000003880 Calendula Nutrition 0.000 claims description 14
- 240000001432 Calendula officinalis Species 0.000 claims description 14
- 244000025254 Cannabis sativa Species 0.000 claims description 14
- 241001479540 Echium vulgare Species 0.000 claims description 14
- 241000219925 Oenothera Species 0.000 claims description 14
- 240000008916 Oenothera biennis Species 0.000 claims description 14
- 240000007313 Tilia cordata Species 0.000 claims description 14
- 230000002579 anti-swelling effect Effects 0.000 claims description 13
- 239000013543 active substance Substances 0.000 claims description 11
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 11
- 239000007908 nanoemulsion Substances 0.000 claims description 11
- 235000013311 vegetables Nutrition 0.000 claims description 11
- 239000007864 aqueous solution Substances 0.000 claims description 10
- 229920005615 natural polymer Polymers 0.000 claims description 10
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 9
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 9
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims description 9
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 claims description 9
- 229940041616 menthol Drugs 0.000 claims description 9
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 9
- 235000007689 Borago officinalis Nutrition 0.000 claims description 8
- 240000004355 Borago officinalis Species 0.000 claims description 8
- 235000005940 Centaurea cyanus Nutrition 0.000 claims description 8
- 240000004385 Centaurea cyanus Species 0.000 claims description 8
- 244000004281 Eucalyptus maculata Species 0.000 claims description 8
- 240000001890 Ribes hudsonianum Species 0.000 claims description 8
- 235000016954 Ribes hudsonianum Nutrition 0.000 claims description 8
- 241000220317 Rosa Species 0.000 claims description 8
- 235000010234 sodium benzoate Nutrition 0.000 claims description 8
- 239000004299 sodium benzoate Substances 0.000 claims description 8
- 239000003381 stabilizer Substances 0.000 claims description 8
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims description 7
- 235000008697 Cannabis sativa Nutrition 0.000 claims description 7
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 claims description 7
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 claims description 7
- 241001312569 Ribes nigrum Species 0.000 claims description 7
- 229940072056 alginate Drugs 0.000 claims description 7
- 235000009120 camo Nutrition 0.000 claims description 7
- 235000005607 chanvre indien Nutrition 0.000 claims description 7
- 229940045761 evening primrose extract Drugs 0.000 claims description 7
- 235000008524 evening primrose extract Nutrition 0.000 claims description 7
- 239000011487 hemp Substances 0.000 claims description 7
- -1 Ca2+ ions Chemical class 0.000 claims description 6
- 235000009024 Ceanothus sanguineus Nutrition 0.000 claims description 6
- 240000003538 Chamaemelum nobile Species 0.000 claims description 6
- 235000007866 Chamaemelum nobile Nutrition 0.000 claims description 6
- 201000004624 Dermatitis Diseases 0.000 claims description 6
- 241000208680 Hamamelis mollis Species 0.000 claims description 6
- 241000721662 Juniperus Species 0.000 claims description 6
- 240000003553 Leptospermum scoparium Species 0.000 claims description 6
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 6
- 235000007232 Matricaria chamomilla Nutrition 0.000 claims description 6
- 244000246386 Mentha pulegium Species 0.000 claims description 6
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 6
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 6
- 240000001439 Opuntia Species 0.000 claims description 6
- 239000010474 borage seed oil Substances 0.000 claims description 6
- 239000002270 dispersing agent Substances 0.000 claims description 6
- 235000001050 hortel pimenta Nutrition 0.000 claims description 6
- 229940118846 witch hazel Drugs 0.000 claims description 6
- 239000003755 preservative agent Substances 0.000 claims description 5
- 230000002335 preservative effect Effects 0.000 claims description 5
- 230000000699 topical effect Effects 0.000 claims description 4
- 230000003712 anti-aging effect Effects 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 150000002500 ions Chemical class 0.000 claims description 3
- 230000001225 therapeutic effect Effects 0.000 claims description 3
- 159000000007 calcium salts Chemical class 0.000 claims description 2
- 239000012266 salt solution Substances 0.000 claims description 2
- 230000003319 supportive effect Effects 0.000 claims 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 abstract description 8
- 230000000694 effects Effects 0.000 abstract description 6
- 241000894007 species Species 0.000 abstract 1
- 239000012071 phase Substances 0.000 description 58
- 239000000047 product Substances 0.000 description 49
- 210000003491 skin Anatomy 0.000 description 29
- 239000000839 emulsion Substances 0.000 description 23
- 238000000527 sonication Methods 0.000 description 23
- 230000008569 process Effects 0.000 description 16
- 239000002088 nanocapsule Substances 0.000 description 13
- 239000003995 emulsifying agent Substances 0.000 description 12
- 239000012467 final product Substances 0.000 description 12
- 238000000265 homogenisation Methods 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 241000195493 Cryptophyta Species 0.000 description 10
- 239000008346 aqueous phase Substances 0.000 description 10
- 239000003153 chemical reaction reagent Substances 0.000 description 10
- 239000013500 performance material Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 229920002451 polyvinyl alcohol Polymers 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- FOIXSVOLVBLSDH-UHFFFAOYSA-N Silver ion Chemical compound [Ag+] FOIXSVOLVBLSDH-UHFFFAOYSA-N 0.000 description 5
- 239000001110 calcium chloride Substances 0.000 description 5
- 229910001628 calcium chloride Inorganic materials 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 206010052428 Wound Diseases 0.000 description 4
- 208000027418 Wounds and injury Diseases 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000010460 hemp oil Substances 0.000 description 4
- 229920002674 hyaluronan Polymers 0.000 description 4
- 229960003160 hyaluronic acid Drugs 0.000 description 4
- 235000014899 silybin Nutrition 0.000 description 4
- 229920001059 synthetic polymer Polymers 0.000 description 4
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 description 3
- 235000010841 Silybum marianum Nutrition 0.000 description 3
- 235000014104 aloe vera supplement Nutrition 0.000 description 3
- 230000004888 barrier function Effects 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000003349 gelling agent Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000009931 harmful effect Effects 0.000 description 3
- 239000008131 herbal destillate Substances 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 239000004584 polyacrylic acid Substances 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 229960003471 retinol Drugs 0.000 description 3
- 235000020944 retinol Nutrition 0.000 description 3
- 239000011607 retinol Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- WZSPWMATVLBWRS-UHFFFAOYSA-N 2-(diethylamino)-n-(2,6-dimethylphenyl)acetamide;n-(2-methylphenyl)-2-(propylamino)propanamide Chemical compound CCCNC(C)C(=O)NC1=CC=CC=C1C.CCN(CC)CC(=O)NC1=C(C)C=CC=C1C WZSPWMATVLBWRS-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- FDQAOULAVFHKBX-UHFFFAOYSA-N Isosilybin A Natural products C1=C(O)C(OC)=CC(C2C(OC3=CC(=CC=C3O2)C2C(C(=O)C3=C(O)C=C(O)C=C3O2)O)CO)=C1 FDQAOULAVFHKBX-UHFFFAOYSA-N 0.000 description 2
- 208000012659 Joint disease Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 241000245063 Primula Species 0.000 description 2
- 235000016311 Primula vulgaris Nutrition 0.000 description 2
- 244000294611 Punica granatum Species 0.000 description 2
- 235000014360 Punica granatum Nutrition 0.000 description 2
- VLGROHBNWZUINI-UHFFFAOYSA-N Silybin Natural products COc1cc(ccc1O)C2OC3C=C(C=CC3OC2CO)C4Oc5cc(O)cc(O)c5C(=O)C4O VLGROHBNWZUINI-UHFFFAOYSA-N 0.000 description 2
- 241000320380 Silybum Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- NWGKJDSIEKMTRX-AAZCQSIUSA-N Sorbitan monooleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NWGKJDSIEKMTRX-AAZCQSIUSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid ester group Chemical group C(CCCCCCCCCCC)(=O)O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 2
- 210000000416 exudates and transudate Anatomy 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 239000010408 film Substances 0.000 description 2
- 239000011888 foil Substances 0.000 description 2
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 description 2
- 229960005277 gemcitabine Drugs 0.000 description 2
- 230000036571 hydration Effects 0.000 description 2
- 238000006703 hydration reaction Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 229940057917 medium chain triglycerides Drugs 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000002539 nanocarrier Substances 0.000 description 2
- 239000002105 nanoparticle Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 150000004492 retinoid derivatives Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 229950000628 silibinin Drugs 0.000 description 2
- 229940043175 silybin Drugs 0.000 description 2
- 230000036560 skin regeneration Effects 0.000 description 2
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical compound CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000036487 Arthropathies Diseases 0.000 description 1
- 101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- 230000005778 DNA damage Effects 0.000 description 1
- 231100000277 DNA damage Toxicity 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102000009123 Fibrin Human genes 0.000 description 1
- 108010073385 Fibrin Proteins 0.000 description 1
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 1
- 229940126043 Galectin-3 inhibitor Drugs 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- DJNTZVRUYMHBTD-UHFFFAOYSA-N Octyl octanoate Chemical compound CCCCCCCCOC(=O)CCCCCCC DJNTZVRUYMHBTD-UHFFFAOYSA-N 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010063493 Premature ageing Diseases 0.000 description 1
- 208000032038 Premature aging Diseases 0.000 description 1
- 244000272459 Silybum marianum Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000010473 blackcurrant seed oil Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940081733 cetearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 125000004386 diacrylate group Chemical group 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000000374 eutectic mixture Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000006882 induction of apoptosis Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000001875 irritant dermatitis Diseases 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 229960005015 local anesthetics Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 235000020727 milk thistle extract Nutrition 0.000 description 1
- 229940096421 milk thistle extract Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N n-hexadecyl alcohol Natural products CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000002121 nanofiber Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 230000004224 protection Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007779 soft material Substances 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 235000003724 spirulina extract Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000012876 topography Methods 0.000 description 1
- 230000036572 transepidermal water loss Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 229920003176 water-insoluble polymer Polymers 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/06—Emulsions
- A61K8/062—Oil-in-water emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/733—Alginic acid; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/95—Involves in-situ formation or cross-linking of polymers
Definitions
- the invention refers to the composition and its use for manufacturing of a cosmetic preparation in the form of a hydrogel bio-mask in the form of a compress.
- the subject of the invention is also a cosmetic preparation in the form of a hydrogel bio-mask in the form of a compress and a method of producing this preparation.
- the preparation according to the invention has regenerative, alleviating, cooling and soothing properties, it is intended for use on the skin.
- Hydrogels are biomaterials consisting of a three-dimensional network of polymer chains and water that fills the spaces between macromolecules.
- Hydrogels can be manufatured by a variety of cross-linking strategies and are classified in different ways. Polysaccharide-based hydrogels are biocompatible, biodegradable and non-toxic. On the other hand, hydrogels based on synthetic polymers are easier to modify and have higher mechanical strength.
- Hydrogels have been used as wound dressings, not only do they create a physical barrier and remove excess exudate, but also provide an environment with appropriate moisture that supports the process of wound stimulation. What's more, the hydrogel can perfectly fill irregularly shaped wounds, dealing with deep hemorrhages.
- Hydrogel dressings are the complete opposite of traditional dressings - they are antibacterial, biodegradable and flexible.
- hydrogels are also utilized in cosmetic products.
- Materials in the form of hydrogel matrices can be extremely valuable systems that allow for uninterrupted or controlled release of biologically active substances comprised in them after injection or direct application on the skin surface. Studies have shown that, apart from the bioactive substances themselves, an important role in increasing their biological effectiveness is also played by the physicochemical form in which the active substances are applied.
- the condition for the activity of active ingredients in cosmetics is the ability to penetrate the epidermis and to reach by the active substance to the appropriate receptor.
- a medical and cosmetic mask which is a flexible hydrogel patch made of synthetic and natural polymers, which is packed removably in foil dividers in a single hermetic foil package.
- the patch has a non-geometric shape with openings for the eyes and an opening for the nose and an opening for the mouth.
- the patch has side incisions for the cheeks and an incision at the bottom for the chin.
- the subject of the application PL238270 is a cosmetic mask used in cosmetic procedures involving the application of nutrients to the face.
- the cosmetic mask is made of a woven or non-woven flexible fibrous structure, laminated on the surface with materials sealing fluid migration or a layer of hydrogel or not laminated, with a shape corresponding to the outline of the face, with openings for the eyes, nose and mouth, provided with incisions directed radially towards the center of the mask, made around its circumference.
- the mask is characterized by the fact that there is a linear or arc perforation in the strip below the incisions or cutouts of the openings intended for the eyes, and the incision or cutout of the opening intended for the mouth. Preferably converging on both sides from the edge of the circumference of the mask to the edge of the intersection or cutout of the opening intended for the nose.
- the invention EP 2 695 604 Al relates to a cosmetic composition for topical application comprising spirulina, which has as main objective to combat the action of free radicals that act on aging.
- the composition according to the invention provides hydration, protection and improvement of the general conditions of the skin.
- EP 2 695 604 Al a recipe of cream with spirulina was disclosed.
- the preparation comprises spirulina in the form of a dry extract in concentrations ranging from 0.1 to 5.0% by weight.
- composition of the preparation includes an emulsifying base (cetearyl alcohol and a mixture of cetyl and stearyl alcohol ethoxylated with 20 moles of ethylene oxide), propylene glycol, glycerin, phenoxyethanol, silicone oils, octyl octanoate and ethoxylated hydrogenated castor oil.
- emulsifying base cetearyl alcohol and a mixture of cetyl and stearyl alcohol ethoxylated with 20 moles of ethylene oxide
- propylene glycol propylene glycol
- glycerin glycerin
- phenoxyethanol phenoxyethanol
- silicone oils octyl octanoate
- ethoxylated hydrogenated castor oil ethoxylated hydrogenated castor oil
- a recipe for nanoemulsion thickened with hydrogel is known from the description of the application of the invention CN109562193 (A).
- the hydrogel matrix was formed using sodium alginate and hyaluronic acid.
- the nanoemulsion consisted of soybean oil, water and a mixture of surfactants, Tween 80 and Span 80.
- Hydrogels are most often used as dressings - bifunctional systems consisting of a hydrophilic, water-insoluble polymer matrix made of natural or synthetic polymers or their mixtures with a three-dimensional cross- linked structure and a solvent, additionally containing medicinal substances or substances supporting the skin regeneration process.
- Polish patent description PL237400B discloses a method of producing a hydrogel dressing with a polymeric hydrogel matrix comprising poly(vinyl alcohol) (PVAL), with which active substances are introduced into the hydrogel matrix, characterized in that the hydrogel matrix is prepared in a process in which: to an aqueous solution of silver nanoparticles with an average particle size of 1 to 100 nm and a temperature of 80 to 90°C, in an amount to obtain a concentration of silver nanoparticles in the hydrogel dressing in the range of 2.00 to 3.00 mg/kg (ppm) for all components of the dressing hydrogel, PVAL is introduced in an amount of 5 to 15% by weight relative to all components of the hydrogel dressing and the solution is stirred for 9 to 12 hours to produce an aqueous solution of silver nanoparticles in PVAL; then the temperature of the aqueous solution of silver nanoparticles in PVA is lowered to a temperature in the range of 68 to 72°C, and then a 14.2% solution of eosin in
- the subject of the application PL432720A is a method of obtaining a hydrogel dressing material based on a natural polymer - sodium alginate and a synthetic polymer - poly(vinyl alcohol), enriched with Aloe vera extract or juice, in which a solution of sodium alginate with a concentration of 1.0 to 2.5 % by weight, in an amount from 10 to 75% by volume relative to the base composition (i.e.
- a mixture consisting of sodium alginate, polyvinyl alcohol and Aloe vera extract or juice is combined at ambient temperature with continuous stirring with an aqueous solution of polyvinyl alcohol, having concentration from 5.0 to 12.5% by weight, in an amount from 10 to 70% by volume and with 2% by weight solution of Aloe vera extract or juice, in the amount of 5 to 25% by volume relative to the base composition, and then the cross-linking agent, which is polyethylene glycol) diacrylate, in the amount of 6.0 to 10% by volume, is introduced to the homogenized mixture with continuous stirring, and the whole is heated to a temperature of 68 to 72°C, then the initiator is introduced, which is a solution of 1% by weight ammonium persulfate, in an amount of 0.8 to 4.2% by volume relative to the base composition, and then the thoroughly mixed composition is subjected to a crosslinking reaction at a temperature of 65 to 80°C for 60 to 120 minutes, followed by a postcrosslinking reaction at room temperature for 24 to 48 hours.
- the nanocapsules were made of polycaprolactone, and their core was medium-chain triglycerides, in which the eutectic mixture was dissolved in a concentration of 5.0%.
- O/W emulsion and evaporation of the organic solvent (acetone and chloroform) method was used. In vivo studies have confirmed long-term surface anesthesia of the oral mucosa during medical and dental procedures.
- LNC was obtained in the phase inversion process from the following raw materials: medium chain triglycerides, water phase (water and NaCl) and a mixture of polyethylene glycol and Span 80 as emulsifiers.
- medium chain triglycerides water phase (water and NaCl)
- Span 80 a mixture of polyethylene glycol and Span 80 as emulsifiers.
- In vitro studies confirmed the cytotoxic effect of the preparation on pancreatic and lung cancer cell lines, higher than for the commercial drug.
- hydrogel with silybin-containing nanocapsules was the subject of research by Rigon and co-authors [Rigon C, Marchiori MCL, da Silva Jardim F, Pegoraro NS, Chaves PDS, Velho MC, Beck RCR, Ourique AF, Sari MHM, Oliveira SM, Cruz L. Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory action in a model of irritant contact dermatitis in mice. Eur J Pharm Sci.
- Alginate hydrogels belong to the group of biocompatible, biodegradable and non-toxic compounds for the human body and the environment. Alginate hydrogels can be produced in various forms, i.e. as films, membranes, fibers/nanofibers, foams.
- the invention also solves the problem of bioavailability of silymarin in cosmetic preparations, and thus removes the barrier in its use.
- composition of hydrogel bio-mask is characterized in that it comprises: a component A and component B combined in a weight ratio of 4: 1 to 1 : 1, where the component A is: a polymer solution, which is from
- spirulina based on the polymer solution, from 0 to 1.2 parts by weight of a mixture of menthol and menthyl lactate relative to the polymer solution, from 0 to 2.5 parts by weight of a preservative, relative to the polymer solution, preferably benzoate sodium
- component B an O/W nanodispersion is: from 85 to 95 parts by weight of water phase, from 4 to 12 parts by weight of the liquid lipid of oil phase, from 1 to 3 parts by weight of the stabilizer of mixture of sorbitan olivate and cetearyl olivate, in which sorbitan olivate from 30 to 50%, and cetearyl olivate from 50 to 70%, from 1 to
- the hydrolate with bacteriostatic and antiseptic properties is lavender hydrolate, or juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate.
- the hydrolate with antiswelling properties is cornflower hydrolate.
- the hydrolate with moisturizing, soothing and alleviating properties is linden flower hydrolate, or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate.
- the liquid lipid of oil phase is borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum).
- the subject of the invention is also use of the composition described above for manufacturing of cosmetic and cosmetic-therapeutic products for topical application with moisturizing, alleviating, regenerating, soothing, anti-swelling and anti-aging effect.
- the cosmetic and/or cosmetic- therapeutic product is chosen from the group of hydrogel compresses comprising active ingredients, preferably in the form of a hydrogel bio-mask.
- the subject of the invention is a cosmetic product a hydrogel bio-mask in the form of a compress, in the form of a hydrogel material of natural origin and natural active ingredients, which is characterized in that it is a combination of a hydrogel matrix obtained from ionically cross-linked alginates from brown algae in a hydrolate environment with bacteriostatic and antiseptic properties and/or a hydrolate with antiswelling properties and/or a hydrolate with moisturizing, soothing and alleviating properties as well as active and active ingredients (component A) and O/W type nanodispersion (component B) based on oils rich in ⁇ -linolenic acid (GLA) comprising a lipophilic active ingredient, wherein component A and component B are combined in a weight ratio of from 4: 1 to 1 : 1.
- GLA ⁇ -linolenic acid
- the component A and thus the hydrogel matrix in the cosmetic product according to the invention comprises spirulina as an active ingredient and/or a mixture of menthol and menthyl lactate as an ingredient with cooling properties.
- the nanodispersion comprises silymarin and/or bakuchiol as lipophilic active ingredients.
- the hydrogel matrix comprises lavender hydrolate, or juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate as hydrolate of bacteriostatic and antiseptic properties.
- the hydrogel matrix comprises cornflower hydrolate as hydrolate with anti-swelling properties.
- hydrogel matrix comprises preferably linden flower hydrolate, or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate. as a hydrolate with moisturizing, soothing and alleviating skin inflammation.
- the O/W type nanodispersion comprises water phase, which constitutes from 85 to 95 parts by weight, the liquid lipid of oil phase which is oil rich in ⁇ -linolenic acid (GLA) in the amount of from 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in the amount from 1 to 3 parts by weight, vegetable glycol, preferably propanediol in the amount from 1 to 3 parts by weight, a lipophilic active ingredient, which is silymarin in the amount from 0.005 to 0.1 parts by weight and/or bakuchiol in the amount from 0.5 to 2 parts by weight.
- GLA ⁇ -linolenic acid
- the O/W type nanodispersion (component B) comprises the active ingredient - silymarin, dissolved in the vegetable glycol, preferably dissolved in propanediol
- the product according to the invention as the liquid lipid of oil phase it comprises borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum).
- borage seed oil Borago officinalis and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum).
- the subject of the invention is also a method of manufacturing the hydrogel biomask based on the natural polymer alginate from brown algae enriched in active substances closed in the form of nanoemulsion, in which method a natural polymer solution is prepared, a component in the form of nanoemulsion comprising an active ingredient is prepared, a cross-linking solution is prepared, and then all components are mixed, characterized in that the aqueous solution of sodium alginate is prepared by dissolving sodium salt of alginic acid from brown algae in a hydrolate with bacteriostatic and antiseptic properties, preferably in lavender hydrolate, and/or in a hydrolate with anti-swelling properties and/or in a hydrolate with moisturizing, soothing and alleviating properties, in at a temperature from 70 to 75°C, then the polymer solution is cooled to ambient temperature and is combined with continuous stirring with spirulina in an amount of 0.33 to 1.65 parts by weight relative to the polymer solution, preferably in an amount of 1 part by weight, is still stirred for
- the component A and component B are combined in a weight ratio of 4:1 to 1 : 1.
- the aqueous solution of sodium alginate - polymer solution - is prepared by dissolving from 0.5 to 5 parts by weight, preferably 3.5 parts by weight, of the sodium salt of alginic acid from brown algae in the hydrolate in an amount of 95 to 99.5 parts by weight, preferably 96.5 parts by weight.
- a hydrolate with bacteriostatic and antiseptic properties was used as a dispersing agent for the preparation of the sodium alginate solution, preferably juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate.
- cornflower hydrolate was used as a dispersing agent for the preparation of the sodium alginate solution.
- a hydrolate with moisturizing, soothing and alleviating skin inflammation properties was used, preferably linden flower hydrolate or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate.
- an O/W nanodispersion which comprises the water phase, which constitutes from 85 to 95 parts by weight, the liquid lipid of the oil phase, which is oil rich in ⁇ -linolenic acid (GLA) in an amount from 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in an amount of 1 to 3 parts by weight, vegetable glycol, preferably propanediol in an amount of 1 to 3 parts by weight, and an active ingredient which is silymarin in an amount of 0.005 to 0.1 part weight and/or bakuchiol in an amount of 0.5 - 2 parts by weight.
- GLA ⁇ -linolenic acid
- borage seed oil Borago officinalis and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum) is used as the liquid lipid of oil phase.
- divalent ions preferably Ca 2+ , are used as the cross-linking agent.
- Ca 2+ ions come from a calcium salt solution, such as a calcium chloride solution.
- a method of manufacturing a hydrogel bio-mask based on a natural polymer, alginate from brown algae, which polymer also comprises spirulina as a hydrophilic active ingredient and is enriched with hydrophobic active substances enclosed in the form of nanoemulsion particles in which method a natural polymer solution comprising spirulina is prepared, a component in the form of a nanoemulsion comprising silymarin and/or bakuchiol is prepared, a cross-linking solution is prepared, and then the individual components are mixed, characterized in that the aqueous solution of sodium alginate is obtained by dissolving in an amount of 0.5 to 5 parts by weight , preferably 3.5 parts by weight of the sodium salt of alginic acid from brown algae, in the selected hydrolate in the amount of 95 to 99.5 parts by weight, preferably 96.5 parts by weight at a temperature of 70-75°C to obtain a polymer solution.
- spirulina is dosed into the system in an amount of 0.33 to 1.65 parts by weight, preferably 1 part by weight relative to the polymer solution, a mixture of menthol and menthyl lactate (Corum 9230) in an amount of 0 to 1.2 parts by weight relative to the polymer solution, preservative available on the market under the name Dermosoft 1388 in an amount of 0 to 2 parts by weight relative to the polymer solution, preservative - sodium benzoate in an amount of 0 to 0.5 parts by weight relative to the polymer solution (component A), constantly stirring on a mechanical stirrer at a constant speed of 1000 -2000 rpm, preferably 1500 rpm, at a temperature of 20-25°C.
- a mechanical stirrer constantly stirring on a mechanical stirrer at a constant speed of 1000 -2000 rpm, preferably 1500 rpm, at a temperature of 20-25°C.
- the previously prepared O/W-type nanodispersion (component B) is introduced into the reaction system in a weight ratio of 4: 1 to 1 : 1.
- Component B is prepared in a separate reaction unit in the following way: first, a pre-emulsion is obtained by mixing at a temperature of 60-80°C, preferably at a temperature of 67-73°C, the water phase, which consists of 85 95 parts by weight of water with the oil phase.
- the liquid lipid of the oil phase is an oil rich in ⁇ -linolenic acid (GLA) in an amount of 4 to 12 parts by weight.
- GLA ⁇ -linolenic acid
- an emulsifier is added in the form of a mixture of sorbitan olivate and cetearyl olivate in the amount of 1 to 3 parts by weight, lipophilic active ingredients, i.e.
- bakuchiol in the amount of 0 - 2 parts by weight and silymarin in the amount of 0.005 to 0.1 parts by weight previously dissolved in vegetable glycol (propanediol), which is used in an amount of 1 to 3 parts by weight.
- the system is stirred on a mechanical stirrer at a speed of 300 to 700 rpm for 5 to 15 minutes, and then the pre-emulsion prepared in this way is homogenized using an ultrasonicator using the sonication amplitude from 69% to 89%, preferably the maximum sonication amplitude should not be exceed 79%, and the sonication power is from 20 - 60 W, preferably 40 W.
- the homogenization process is carried out for a period of 60 to 2400 s, preferably 180.
- the prepared systems are combined using a mechanical stirrer with a constant rotational speed of 1500 rpm for 1-5 minutes, preferably 2 minutes at a temperature of 25°C. Then the resulting reaction mixture is placed in a refrigerator at a temperature of 4-7 °C for 24 hours. After this time, the obtained product is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then the reaction mixture is transferred to a Petri dish, a cross-linking agent - component C is added and the proper ionic crosslinking reaction is carried out. The cross-linking agent is added to the reaction system in a 2: 1 weight ratio to the amount of the starting composition.
- the cross-linking agent is prepared by dissolving 5 parts by weight of anhydrous calcium chloride in 95 parts by weight of water (component C). The ionic cross-linking reaction is carried out for a period of 15-45 minutes, preferably 30 minutes, at a temperature of 22-25°C. The cross-linked hydrogel compositions are then washed with distilled water to remove residual cross-linking agent, yielding a final product that can be given any shape. The final shape of the final product results from its intended use and it is a compress for use on the skin.
- the product may be in the form of a mask, which is a compress to be applied to the face.
- the skeleton of the hydrogel matrix is made up of polysaccharides in the form of alginates from brown algae, which are biocompatible, biodegradable, non-toxic and safe to use.
- hydrogels are not absorbed from the surface of the skin, but leave a transparent layer on it that protects against external factors and microorganisms. They also have absorptive properties, so they can absorb exudate from wounds, accelerating the healing process and regenerating damaged tissues.
- hydrolates used in the production of the preparation according to the invention enable the skin to restore its proper, slightly acidic pH, thus protecting the skin against the harmful effects of external factors and maintaining its physiological microbiome.
- the use of hydrolates for the production of a cosmetic product in the form of a hydrogel bio-mask has an impact on reducing water consumption in the cosmetics industry.
- the silymarin used in the product according to the invention is an active complex of flavonolignans obtained from the seed shells of milk thistle (Silybum marianum). It is an effective antioxidant and anti-inflammatory agent. It has the ability to eliminate the harmful effects of UV radiation, reduces possible allergic reactions, swelling, erythema caused by this radiation, reduces DNA damage and inhibits the induction of apoptosis (cell death). It is recommended to use silymarin in case of allergic problems and skin inflammations. There are research results showing the antiaging properties of silymarin in relation to skin cells, these properties result from the stimulating effect of silymarin on keratinocytes, which causes the synthesis of collagen and elastin. Due to the fact that this substance is characterized by very low solubility in both water and fats, thus limiting its bioavailability, which is a barrier to its use in cosmetic preparations, and thus.
- the bakuchiol used in the preparation is a chemical compound called plant retinol due to its almost identical action, but without the side effects that apply to retinol and retinoid. Like retinol and retinoid, it has an exfoliating and normalizing effect, reduces wrinkles, furrows and helps to remove discoloration, normalizes sebum secretion, eliminates acne, rejuvenates and delays skin aging.
- oils rich in ⁇ -linolenic acid which is a precursor of prostaglandin responsible for the proper condition of the skin, used in the preparation, show synergistic effects with the components of the solution according to the invention.
- GLA ⁇ -linolenic acid
- Particularly valuable plant raw materials for obtaining oils rich in GLA are the seeds:
- black currant seeds (Ribes nigrum ;
- Spirulina blue-green algae
- Spirulina has a very rich composition, because it comprises many active and nutritional substances, thanks to which it improves blood circulation, evens skin tone and is responsible for regulating the activity of sebaceous glands.
- it has an antioxidant effect, neutralizes harmful free radicals, thus protecting the skin against premature aging, it also has a soothing, anti-inflammatory and anti-allergic effect (inhibits the secretion of histamine).
- nanodispersion in the hydrogel matrix of the preparation increases the bioavailability of the lipophilic extract from milk thistle seeds - silymarin, and affects its stability and protects this component against external factors, while extending its action to a much greater extent than conventional preparations (creams), where it is available on the market.
- this form of delivery of the lipophilic active ingredient ensures deeper skin penetration, which will enhance the effectiveness of the preparation.
- An additional advantage of the preparation is the introduction of nanoformulation into the hydrogel matrix, to which spirulina and hydrolate have previously been introduced. This combination of active ingredients increases the effectiveness of the preparation, regenerating and soothing, due to the content of many active substances with different properties.
- the nanocarrier/hydrogel matrix systems are characterized by controlled release, resulting in prolonged exposure of the skin to the active ingredient in the formulation of the invention.
- the nanoparticles of the internal phase of the nanoemulsion comprising the lipophilic active substance (silymarin) in the first stage of action are released into the hydrogel matrix, which is cross-linked, which means that the particles of the penetrating active substance are captured and slowly released by the cross-linked structure.
- the exposure of the skin to the lipophilic component is prolonged.
- This combination also allows to extend the contact time of the preparation with the skin and increases the degree of hydration of the skin by creating a hydrophilic film on its surface and limiting transepidermal water loss. This is a very important aspect in the process of skin regeneration.
- hydrolates used in the preparation as a dispersing phase in the hydrogel matrix enhance the regenerating effect of spirulina and milk thistle extract, and additionally provide bacteriostatic, antiswelling, moisturizing, soothing and alleviating inflammatory effects on the skin.
- Fig. 1 shows an exemplary appearance of a cosmetic preparation in the form of a hydrogel face mask
- Fig. 2 shows other examples of a cosmetic preparation in the form of compresses of various sizes and with different content of component B
- Fig. 3 shows the morphology and the surface topography of the hydrogel mask of the invention by SEM analysis.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
- Component (B) 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- a solution of silymarin in propanediol is added to the oil phase thus prepared.
- the ingredients of the aqueous phase water are then weighed in an amount of 87 parts by weight.
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
- Component (C) 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
- Component (B) 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- a solution of silymarin in propanediol is added to the oil phase thus prepared.
- the ingredients of the aqueous phase water are then weighed in an amount of 87 parts by weight.
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
- Component (C) 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 2: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
- Component (B) 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- a solution of silymarin in propanediol is added to the oil phase thus prepared.
- the ingredients of the aqueous phase water are then weighed in an amount of 87 parts by weight.
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
- Component (C) 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 3: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
- Component (A) The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in lavender hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - polymer solution. Then, spirulina is dosed into the system in the amount of 1 part by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
- Component (B) 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol.
- borage oil 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- a solution of silymarin in propanediol is added to the oil phase thus prepared.
- the ingredients of the aqueous phase water are then weighed in an amount of 87 parts by weight.
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
- Component (C) 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 1 : 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; eucalyptus hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
- Component (B) 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 8 parts by weight of borage oil, and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- a solution of silymarin in propanediol is added to the oil phase thus prepared.
- the ingredients of the aqueous phase water are then weighed in an amount of 87 parts by weight.
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 89% and the sonication time of 120 s.
- Component (C) 5 g CaCl 2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- a Petri dish ( ⁇ ) 18,5cm) carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2:1 to the amount of the reaction mixture to be cross-linked.
- the ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C.
- the cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross- linking agent.
- a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; neroli hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", hemp oil - Olvita, demineralized water, Dermosoft 1388 - Evonik Dr. Straetmans GmbH, sodium benzoate - Sigma Aldrich. Solution (A):
- the sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in neroli hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - polymer solution. Then, into the system they are dosed: spirulina in the amount of 0.5 part by weight relative to the polymer solution, a mixture of menthol and menthyl lactate (Corum 9230) in the amount 0.5 parts by weight relative to the polymer solution, Dermosoft 1388 in the amount 2 parts by weight and sodium benzoate in the amount 0.5 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 15 minutes, at a temperature of 20-25°C.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 69% and the sonication time of 180 s.
- Component (C) 5 g CaCl 2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 3: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; cornflower hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", black currant seeds oil - Olvita, demineralized water, Dermosoft 1388 - Evonik Dr. Straetmans GmbH, sodium benzoate - Sigma Aldrich.
- the sodium salt of alginic acid obtained from brown algae in the amount of 1.5 parts by weight is dissolved in cornflower hydrolate in the amount of 98.5 parts by weight, at the temperature of 70-75°C - (polymer solution). Then, into the system they are dosed: spirulina in the amount of 1.5 part by weight relative to the polymer solution, a mixture of menthol and menthyl lactate (Corum 9230) in the amount 0.25 parts by weight relative to the polymer solution, Dermosoft 1388 in the amount 2 parts by weight and sodium benzoate in the amount 0.5 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 15 minutes, at a temperature of 20-25°C.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
- Component (C) 5 g CaCl 2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 1 : 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; linden flower hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", primrose oil - Olvita, demineralized water, Dermosoft 1388 - Evonik Dr. Straetmans GmbH
- Component (B) 0.005 parts by weight of silymarin is dissolved in 2 parts by weight of propanediol. 8 parts by weight of primrose oil, and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase. A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 89% and the sonication time of 180 s.
- Component (C) 5 g CaCl 2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; rose hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECOSPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", borage oil - Olvita, demineralized water.
- the sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in rose hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - (polymer solution). Then, into the system they are dosed: spirulina in the amount of 0.5 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 15 minutes, at a temperature of 20-25°C.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 60 W, the amplitude of 89% and the sonication time of 240 s.
- Component (C) 5 g CaCl 2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 1 : 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Reagents sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem”; calendula hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Tru S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", hemp oil - Olvita, demineralized water.
- the sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in calendula hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - (polymer solution). Then, into the system they are dosed: spirulina in the amount of 1.0 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
- O/W emulsifier a mixture of sorbitan olivate and cetearyl olivate
- the obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
- Component (C) 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
- component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute.
- Chart No. 1 shows the effect of spirulina addition and nanodispersion on the viscosity of alginate systems before the actual crosslinking reaction
- Chart 1 presents the viscosity results for the systems that were used to obtain the bio-mask in Example 4.
- Chart 2 shows the Shore C hardness results for selected products - hydrogel bio-masks from examples 1-4.
- Chart 2 presents the hardness results for the reference sample, which is a hydrogel matrix containing spirulina in the amount described in examples 1-4 (component A), but without the addition of nanodispersions (component B), and biomasks with different amounts of nanodispersions.
- component A a hydrogel matrix containing spirulina in the amount described in examples 1-4
- component B nanodispersions
- biomasks with different amounts of nanodispersions.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dispersion Chemistry (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a composition of hydrogel bio-mask, a cosmetic product a hydrogel bio-mask in the form of a compress, in the form of a hydrogel material of natural origin and natural active ingredients, which is characterized in that it is a combination of a hydrogel matrix obtained from ionically cross-linked alginates from brown algae in a hydrolate environment with bacteriostatic and antiseptic properties, preferably lavender hydrolate, which comprises active ingredient spirulina, and nanodispersion comprising lipophilic active ingredient silymarin and/or bakuchiol. The product according to the invention comprises ingredients of 100% natural origin. The preparation comprises active ingredients acting synergistically with regenerative, moisturizing, and alleviating effect: spirulina and sylimarin and lavender hydrolate obtained from species of lavender Lavandula angustifolia cultivated in Poland in Świętokrzyskie region, and oils rich in γ-linolenic acid (GLA). The object of the present invention is also a method of manufacturing the product hydrogel bio-mask.
Description
COMPOSITION, APPLICATION OF THE COMPOSITION, COSMETIC PREPARATION HYDROGEL BIO-MASK IN THE FORM OF A COMPRESS, METHOD OF MANUFACTURING THE PREPARATION
TECHNICAL FIELD
The invention refers to the composition and its use for manufacturing of a cosmetic preparation in the form of a hydrogel bio-mask in the form of a compress. The subject of the invention is also a cosmetic preparation in the form of a hydrogel bio-mask in the form of a compress and a method of producing this preparation. The preparation according to the invention has regenerative, alleviating, cooling and soothing properties, it is intended for use on the skin.
BACKGROUND ART
Hydrogels are biomaterials consisting of a three-dimensional network of polymer chains and water that fills the spaces between macromolecules.
Hydrogels can be manufatured by a variety of cross-linking strategies and are classified in different ways. Polysaccharide-based hydrogels are biocompatible, biodegradable and non-toxic. On the other hand, hydrogels based on synthetic polymers are easier to modify and have higher mechanical strength.
Hydrogels have been used as wound dressings, not only do they create a physical barrier and remove excess exudate, but also provide an environment with appropriate moisture that supports the process of wound stimulation. What's more, the hydrogel can perfectly fill irregularly shaped wounds, dealing with deep hemorrhages.
Hydrogel dressings are the complete opposite of traditional dressings - they are antibacterial, biodegradable and flexible.
The extraordinary properties of hydrogels are also utilized in cosmetic products.
Materials in the form of hydrogel matrices can be extremely valuable systems that allow for uninterrupted or controlled release of biologically active substances comprised in them after injection or direct application on the skin surface. Studies have shown that, apart from the bioactive substances themselves, an important role in increasing their biological effectiveness is also played by the physicochemical form in which the active substances are applied.
The condition for the activity of active ingredients in cosmetics is the ability to penetrate the epidermis and to reach by the active substance to the appropriate receptor.
Due to the commonly visible attachment to taking care of the good condition of the skin and the fight against any imperfections or diseases, there is currently a large demand for products intended for the care and treatment of skin diseases. Therefore, there is an increasing demand for innovative products that are to contribute to meeting this challenge. Numerous studies have proven that hydrogel materials can be very helpful in this fight.
The following solutions are known from the state of the art:
From the description of the utility model application W.104254, a medical and cosmetic mask is known, which is a flexible hydrogel patch made of synthetic and natural polymers, which is packed removably in foil dividers in a single hermetic foil package. The patch has a non-geometric shape with openings for the eyes and an opening for the nose and an opening for the mouth. The patch has side incisions for the cheeks and an incision at the bottom for the chin.
The subject of the application PL238270 is a cosmetic mask used in cosmetic procedures involving the application of nutrients to the face. The cosmetic mask is made of a woven or non-woven flexible fibrous structure, laminated on the surface with materials sealing fluid migration or a layer of hydrogel or not laminated, with a shape corresponding to the outline of the face, with openings for the eyes, nose and mouth, provided with incisions directed radially towards the center of the mask, made around its circumference. The mask is characterized by the fact that there is a linear or arc perforation in the strip below the incisions or cutouts of the openings intended for the eyes, and the incision or cutout of the opening intended for the mouth. Preferably converging on both sides from the edge of the circumference of the mask to the edge of the intersection or cutout of the opening intended for the nose.
The invention EP 2 695 604 Al relates to a cosmetic composition for topical application comprising spirulina, which has as main objective to combat the action of free radicals that act on aging. The composition according to the invention provides hydration, protection and improvement of the general conditions of the skin. In the European patent application EP 2 695 604 Al a recipe of cream with spirulina was disclosed. The preparation comprises spirulina in the form of a dry extract in concentrations ranging from 0.1 to 5.0% by weight. The composition of the preparation includes an emulsifying base (cetearyl alcohol and a mixture of cetyl and
stearyl alcohol ethoxylated with 20 moles of ethylene oxide), propylene glycol, glycerin, phenoxyethanol, silicone oils, octyl octanoate and ethoxylated hydrogenated castor oil.
A recipe for nanoemulsion thickened with hydrogel is known from the description of the application of the invention CN109562193 (A). The hydrogel matrix was formed using sodium alginate and hyaluronic acid. The nanoemulsion consisted of soybean oil, water and a mixture of surfactants, Tween 80 and Span 80.
Hydrogels, known from the state of the art, are most often used as dressings - bifunctional systems consisting of a hydrophilic, water-insoluble polymer matrix made of natural or synthetic polymers or their mixtures with a three-dimensional cross- linked structure and a solvent, additionally containing medicinal substances or substances supporting the skin regeneration process.
Polish patent description PL237400B discloses a method of producing a hydrogel dressing with a polymeric hydrogel matrix comprising poly(vinyl alcohol) (PVAL), with which active substances are introduced into the hydrogel matrix, characterized in that the hydrogel matrix is prepared in a process in which: to an aqueous solution of silver nanoparticles with an average particle size of 1 to 100 nm and a temperature of 80 to 90°C, in an amount to obtain a concentration of silver nanoparticles in the hydrogel dressing in the range of 2.00 to 3.00 mg/kg (ppm) for all components of the dressing hydrogel, PVAL is introduced in an amount of 5 to 15% by weight relative to all components of the hydrogel dressing and the solution is stirred for 9 to 12 hours to produce an aqueous solution of silver nanoparticles in PVAL; then the temperature of the aqueous solution of silver nanoparticles in PVA is lowered to a temperature in the range of 68 to 72°C, and then a 14.2% solution of eosin in a solvent consisting of a mixture of glycerin and water in a weight ratio of 1 :5 is added to the aqueous solution of silver nanoparticles in PVAL in an amount to obtain an eosin concentration in the hydrogel dressing in the range of 1 to 3% by weight, relative to all components of the hydrogel dressing, and the resulting composition is stirred for 1 to 2 hours; then the temperature of the resulting composition is lowered to a temperature in the range of 62 to 67°C, and then a 2.4% solution of allantoin in a solvent consisting of a mixture of propylene glycol and water is introduced to the composition in a weight ratio of 1 :3 in an amount to obtain the concentration of allantoin in the hydrogel dressing in the range of 0.1 to 0.3 wt% relative to all components of the hydrogel dressing, and the composition is stirred for 1 to 2 hours;
then the temperature of the composition is lowered to a temperature in the range of 58 to 62°C, after which the preservative is introduced into the composition in an amount of 0.5 to 1.0% by weight relative to all components of the hydrogel dressing, the composition is continuously stirred for 20 to 40 minutes, after which a thickener is introduced into the composition in an amount of 2 to 10% by weight relative to all components of the hydrogel dressing, the composition is continuously stirred for 20 to 40 minutes; and the temperature of the composition is lowered to a value in the range of 48 to 52°C, then 10% sodium hydroxide (NaOH) solution is introduced into the composition in an amount necessary to obtain a pH value of the composition in the range of 5.8 to 7 and the composition is stirred for 20 to 40 minutes to form a hydrogel dressing. The subject of the application is also a hydrogel dressing obtained in this way.
The subject of the application PL432720A is a method of obtaining a hydrogel dressing material based on a natural polymer - sodium alginate and a synthetic polymer - poly(vinyl alcohol), enriched with Aloe vera extract or juice, in which a solution of sodium alginate with a concentration of 1.0 to 2.5 % by weight, in an amount from 10 to 75% by volume relative to the base composition (i.e. a mixture consisting of sodium alginate, polyvinyl alcohol and Aloe vera extract or juice), is combined at ambient temperature with continuous stirring with an aqueous solution of polyvinyl alcohol, having concentration from 5.0 to 12.5% by weight, in an amount from 10 to 70% by volume and with 2% by weight solution of Aloe vera extract or juice, in the amount of 5 to 25% by volume relative to the base composition, and then the cross-linking agent, which is polyethylene glycol) diacrylate, in the amount of 6.0 to 10% by volume, is introduced to the homogenized mixture with continuous stirring, and the whole is heated to a temperature of 68 to 72°C, then the initiator is introduced, which is a solution of 1% by weight ammonium persulfate, in an amount of 0.8 to 4.2% by volume relative to the base composition, and then the thoroughly mixed composition is subjected to a crosslinking reaction at a temperature of 65 to 80°C for 60 to 120 minutes, followed by a postcrosslinking reaction at room temperature for 24 to 48 hours.
Known from the literature are combinations of nanoformulations and hydrogel matrices. Muniz and associates [Muniz, B.V., Baratelli, D., Di Carla, S. et al. Hybrid Hydrogel Composed of Polymeric Nanocapsules Co-Loading Lidocaine and Prilocaine for Topical Intraoral Anesthesia. Sci Rep 8, 17972 (2018)] developed a
hybrid hydrogel comprising polymeric nanocapsules into which lidocaine and prilocaine, drugs for local anesthetics, were incorporated. The hydrogel matrix consisted of: polyacrylic acid, propylene glycol, glycerin, paraben, triethanolamine and water. The nanocapsules were made of polycaprolactone, and their core was medium-chain triglycerides, in which the eutectic mixture was dissolved in a concentration of 5.0%. In order to prepare the nanocapsules, the O/W emulsion and evaporation of the organic solvent (acetone and chloroform) method was used. In vivo studies have confirmed long-term surface anesthesia of the oral mucosa during medical and dental procedures.
Moysan with the team [Moysan E, Gonzalez-Fernandez Y, Lautram N, Bejaud J, Bastiat G, Benoit JP. An innovative hydrogel of gemcitabine-loaded lipid nanocapsules: when the drug is a key player of the nanomedicine structure. Soft Matter. 2014 Mar 21; 10(11): 1767-77] developed a modern method of obtaining a hydrogel matrix in which lipid nanocapsules (LNC) comprising gemcitabine modified with lauric acid were suspended. The essence of the innovative solution was the fact that the active compound also acted as a gelling agent. LNC was obtained in the phase inversion process from the following raw materials: medium chain triglycerides, water phase (water and NaCl) and a mixture of polyethylene glycol and Span 80 as emulsifiers. In vitro studies confirmed the cytotoxic effect of the preparation on pancreatic and lung cancer cell lines, higher than for the commercial drug.
According to data from another publication Storozhylova and team [Storozhylova, N., Crecente-Campo, J., Cabaleiro, D. et al. An In Situ Hyaluronic Acid-Fibrin Hydrogel Containing Drug-Loaded Nanocapsules for Intra-Articular Treatment of Inflammatory Joint Diseases. Regen. Eng. Transl. Med. 6, 201-216 (2020)] received a hydrogel based on fibrin and hyaluronic acid (HA), into which nanocapsules with dexamethasone and galectin-3 inhibitor were introduced. The core of the nanocapsules was olive oil, and the shell was soy lecithin and oleylamine, grafted with hyaluronic acid. Their size was 122-135 nm. In vivo studies confirmed the anti-inflammatory effect of the obtained preparation and the potential in the treatment of arthropathies.
The hydrogel with silybin-containing nanocapsules was the subject of research by Rigon and co-authors [Rigon C, Marchiori MCL, da Silva Jardim F, Pegoraro NS, Chaves PDS, Velho MC, Beck RCR, Ourique AF, Sari MHM, Oliveira SM, Cruz L. Hydrogel containing silibinin nanocapsules presents effective anti-inflammatory
action in a model of irritant contact dermatitis in mice. Eur J Pharm Sci. 2019 Sep 1;137: 104969], A copolymer of acrylic acid and alkyl methacrylate was used as the gelling agent, and in earlier studies gellan gum [Marchiori MCL, Rigon C, Camponogara C, Oliveira SM, Cruz L. Hydrogel containing silibinin-loaded pomegranate oil based nanocapsules exhibits anti-inflammatory effects on skin damage UVB radiation-induced in mice. J Photochem Photobiol B. 2017 May; 170:25- 32], The nanocapsules consisted of sorbitan monooleate (0.77%), pomegranate seed oil (3%), ethylcellulose (1%) and silybin (0.1%). In vivo studies have confirmed the efficacy of the preparation obtained in the treatment of skin inflammations.
On the other hand Eid with the team [Eid, Ahmad & Elmarzugi, Nagib & El Enshasy, Hesham. (2013). Development of Avocado oil Nanoemulsion Hydrogel using Sucrose Ester Stearate. Journal of Applied Pharmaceutical Science. 3. 145-147] developed a nanoemulsion based on avocado oil, stabilized with sucrose stearate, which was then cross-linked with carbomer, i.e. polyacrylic acid.
In recent years, there have been many literature reports on the hybrid combination of a hydrogel structure and colloidal nanocarriers as potential systems for the delivery of medicinal substances via the transdermal, oral, conjunctival and mucous membrane routes.
According to Desfrangois et al [Desfrangois C, Auzely R, Texier I. Lipid Nanoparticles and Their Hydrogel Composites for Drug Delivery: A Review. Pharmaceuticals (Basel). 2018 Nov 1;11(4): 118] in the last twenty years, gelling agents used to obtain hydrogels were mainly polyacrylic acid (26%), polysaccharides (24%) and poloxamers (9%). Among the polysaccharides, the most popular are chitosan (27%), xanthan gum (27%), cellulose (23%), dextran (13%) and alginates (10%).
It is known from the state of the art that among many natural polymers used to obtain hydrogel materials for dressings, polysaccharides, including alginates, have beneficial application properties. Alginate hydrogels belong to the group of biocompatible, biodegradable and non-toxic compounds for the human body and the environment. Alginate hydrogels can be produced in various forms, i.e. as films, membranes, fibers/nanofibers, foams.
The above information from the state of the art shows that there are no known cosmetic preparations in the form of a hydrogel bio-mask formed as a result of combining an alginate composition in a hydrolate with specific properties, additionally
comprising spirulina, and a nanodispersion comprising silymarin and/or bakuchiol, by ionic cross-linking, which leads to obtaining a hydrogel matrix in the form of a compress, in which both the components that form the hydrogel matrix, as well as the active ingredients are of natural origin.
The invention also solves the problem of bioavailability of silymarin in cosmetic preparations, and thus removes the barrier in its use.
DISCLOSURE OF THE INVENTION
According to the invention a composition of hydrogel bio-mask is characterized in that it comprises: a component A and component B combined in a weight ratio of 4: 1 to 1 : 1, where the component A is: a polymer solution, which is from
0.5 to 5 parts by weight of sodium salt of alginic acid from brown algae and from 95 to 99.5 parts by weight of a hydrolate with bacteriostatic and antiseptic properties and/or anti-swelling properties and/or moisturizing, soothing and alleviating properties, and from 0.33 to 1.65 parts by weight of spirulina based on the polymer solution, from 0 to 1.2 parts by weight of a mixture of menthol and menthyl lactate relative to the polymer solution, from 0 to 2.5 parts by weight of a preservative, relative to the polymer solution, preferably benzoate sodium, and the component B an O/W nanodispersion is: from 85 to 95 parts by weight of water phase, from 4 to 12 parts by weight of the liquid lipid of oil phase, from 1 to 3 parts by weight of the stabilizer of mixture of sorbitan olivate and cetearyl olivate, in which sorbitan olivate from 30 to 50%, and cetearyl olivate from 50 to 70%, from 1 to 3 parts by weight of vegetable glycol, propanediol, from 0.005 to 0.1 parts by weight of the lipophilic active ingredient, silymarin, from 0.5 to 2 parts by weight of bakuchiol.
Preferably in the composition according to the invention the hydrolate with bacteriostatic and antiseptic properties is lavender hydrolate, or juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate.
Preferably in the composition according to the invention the hydrolate with antiswelling properties is cornflower hydrolate.
Preferably in the composition according to the invention the hydrolate with moisturizing, soothing and alleviating properties is linden flower hydrolate, or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate.
Preferably in the composition according to the invention the liquid lipid of oil phase is borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum).
The subject of the invention is also use of the composition described above for manufacturing of cosmetic and cosmetic-therapeutic products for topical application with moisturizing, alleviating, regenerating, soothing, anti-swelling and anti-aging effect.
In the preferable version of the invention the cosmetic and/or cosmetic- therapeutic product is chosen from the group of hydrogel compresses comprising active ingredients, preferably in the form of a hydrogel bio-mask.
The subject of the invention is a cosmetic product a hydrogel bio-mask in the form of a compress, in the form of a hydrogel material of natural origin and natural active ingredients, which is characterized in that it is a combination of a hydrogel matrix obtained from ionically cross-linked alginates from brown algae in a hydrolate environment with bacteriostatic and antiseptic properties and/or a hydrolate with antiswelling properties and/or a hydrolate with moisturizing, soothing and alleviating properties as well as active and active ingredients (component A) and O/W type nanodispersion (component B) based on oils rich in γ-linolenic acid (GLA) comprising a lipophilic active ingredient, wherein component A and component B are combined in a weight ratio of from 4: 1 to 1 : 1.
Preferably the component A, and thus the hydrogel matrix in the cosmetic product according to the invention comprises spirulina as an active ingredient and/or a mixture of menthol and menthyl lactate as an ingredient with cooling properties.
Preferably the nanodispersion comprises silymarin and/or bakuchiol as lipophilic active ingredients.
Preferably the hydrogel matrix comprises lavender hydrolate, or juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate as hydrolate of bacteriostatic and antiseptic properties.
Preferably the hydrogel matrix comprises cornflower hydrolate as hydrolate with anti-swelling properties.
Preferably hydrogel matrix comprises preferably linden flower hydrolate, or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate. as a hydrolate with moisturizing, soothing and alleviating skin inflammation.
Preferably the O/W type nanodispersion (component B) comprises water phase, which constitutes from 85 to 95 parts by weight, the liquid lipid of oil phase which is oil rich in γ-linolenic acid (GLA) in the amount of from 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in the amount from 1 to 3 parts by weight, vegetable glycol, preferably propanediol in the amount from 1 to 3 parts by weight, a lipophilic active ingredient, which is silymarin in the amount from 0.005 to 0.1 parts by weight and/or bakuchiol in the amount from 0.5 to 2 parts by weight.
Preferably the O/W type nanodispersion (component B) comprises the active ingredient - silymarin, dissolved in the vegetable glycol, preferably dissolved in propanediol
Preferably the product according to the invention as the liquid lipid of oil phase it comprises borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum).
The subject of the invention is also a method of manufacturing the hydrogel biomask based on the natural polymer alginate from brown algae enriched in active substances closed in the form of nanoemulsion, in which method a natural polymer solution is prepared, a component in the form of nanoemulsion comprising an active ingredient is prepared, a cross-linking solution is prepared, and then all components are mixed, characterized in that the aqueous solution of sodium alginate is prepared by dissolving sodium salt of alginic acid from brown algae in a hydrolate with bacteriostatic and antiseptic properties, preferably in lavender hydrolate, and/or in a
hydrolate with anti-swelling properties and/or in a hydrolate with moisturizing, soothing and alleviating properties, in at a temperature from 70 to 75°C, then the polymer solution is cooled to ambient temperature and is combined with continuous stirring with spirulina in an amount of 0.33 to 1.65 parts by weight relative to the polymer solution, preferably in an amount of 1 part by weight, is still stirred for 3 to 5 minutes, then to the reaction system is introduced from 0.0 to 1.2 parts by weight of a mixture of menthol and menthyl lactate relative to the polymer solution, from 0 to 2 parts by weight of a mixture of sorbitan olivate and cetearyl olivate relative on the polymer solution, from 0 to 0.5 parts by weight of sodium benzoate relative to the polymer solution and is still stirred for a period of 5 to 15 minutes (component A), then, into the reaction system an O/W type nanodispersion - (component B) is introduced, where the component B comprises a water phase, which constitutes from 85 to 95 parts by weight, a liquid lipid of the oil phase, which is an oil rich in γ-linolenic acid (GLA) in an amount of 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in an amount of 1 to 3 parts by weight, vegetable glycol, preferably propanediol in an amount of 1 to 3 parts by weight and a lipophilic active ingredient which is silymarin in an amount of 0.005 to 0.1 part by weight and/or bakuchiol in an amount of 0.5 - 2 parts by weight, the reaction mixture is stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1-5 minutes, preferably for a period of 2 minutes while maintaining the temperature of the reaction environment at 25°C, then the resulting reaction mixture is placed at a temperature of 4-7°C for 24 hours, after this time, the obtained product is gradually heated to a temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm min for 1 minute, then the crosslinking agent is introduced into the reaction system in a volume ratio of 2:1 relative to the reaction mixture, which contains 5 parts by weight of anhydrous calcium chloride in 95 parts by weight of distilled water (component C), the composition is crosslinked at a temperature of 20 -25°C for a period of 15 to 45 minutes, preferably 30 minutes, then the obtained product is washed with water.
Preferably the component A and component B are combined in a weight ratio of 4:1 to 1 : 1.
Preferably the aqueous solution of sodium alginate - polymer solution - is prepared by dissolving from 0.5 to 5 parts by weight, preferably 3.5 parts by weight,
of the sodium salt of alginic acid from brown algae in the hydrolate in an amount of 95 to 99.5 parts by weight, preferably 96.5 parts by weight.
Preferably a hydrolate with bacteriostatic and antiseptic properties was used as a dispersing agent for the preparation of the sodium alginate solution, preferably juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate.
Preferably cornflower hydrolate, was used as a dispersing agent for the preparation of the sodium alginate solution.
Preferably as a dispersing agent for the preparation of the sodium alginate solution, a hydrolate with moisturizing, soothing and alleviating skin inflammation properties was used, preferably linden flower hydrolate or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate.
Preferably in the method according to the invention as the component B - an O/W nanodispersion is used, which comprises the water phase, which constitutes from 85 to 95 parts by weight, the liquid lipid of the oil phase, which is oil rich in γ-linolenic acid (GLA) in an amount from 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in an amount of 1 to 3 parts by weight, vegetable glycol, preferably propanediol in an amount of 1 to 3 parts by weight, and an active ingredient which is silymarin in an amount of 0.005 to 0.1 part weight and/or bakuchiol in an amount of 0.5 - 2 parts by weight.
Preferably borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum) is used as the liquid lipid of oil phase.
Preferably divalent ions, preferably Ca2+, are used as the cross-linking agent.
Preferably Ca2+ ions come from a calcium salt solution, such as a calcium chloride solution.
According to the invention, a method of manufacturing a hydrogel bio-mask based on a natural polymer, alginate from brown algae, which polymer also comprises spirulina as a hydrophilic active ingredient and is enriched with hydrophobic active substances enclosed in the form of nanoemulsion particles, in which method a natural polymer solution comprising spirulina is prepared, a component in the form of a nanoemulsion comprising silymarin and/or bakuchiol is prepared, a cross-linking
solution is prepared, and then the individual components are mixed, characterized in that the aqueous solution of sodium alginate is obtained by dissolving in an amount of 0.5 to 5 parts by weight , preferably 3.5 parts by weight of the sodium salt of alginic acid from brown algae, in the selected hydrolate in the amount of 95 to 99.5 parts by weight, preferably 96.5 parts by weight at a temperature of 70-75°C to obtain a polymer solution.
Then spirulina is dosed into the system in an amount of 0.33 to 1.65 parts by weight, preferably 1 part by weight relative to the polymer solution, a mixture of menthol and menthyl lactate (Corum 9230) in an amount of 0 to 1.2 parts by weight relative to the polymer solution, preservative available on the market under the name Dermosoft 1388 in an amount of 0 to 2 parts by weight relative to the polymer solution, preservative - sodium benzoate in an amount of 0 to 0.5 parts by weight relative to the polymer solution (component A), constantly stirring on a mechanical stirrer at a constant speed of 1000 -2000 rpm, preferably 1500 rpm, at a temperature of 20-25°C.
Then, the previously prepared O/W-type nanodispersion (component B) is introduced into the reaction system in a weight ratio of 4: 1 to 1 : 1.
Component B is prepared in a separate reaction unit in the following way: first, a pre-emulsion is obtained by mixing at a temperature of 60-80°C, preferably at a temperature of 67-73°C, the water phase, which consists of 85 95 parts by weight of water with the oil phase. The liquid lipid of the oil phase is an oil rich in γ-linolenic acid (GLA) in an amount of 4 to 12 parts by weight. Then, an emulsifier is added in the form of a mixture of sorbitan olivate and cetearyl olivate in the amount of 1 to 3 parts by weight, lipophilic active ingredients, i.e. bakuchiol in the amount of 0 - 2 parts by weight and silymarin in the amount of 0.005 to 0.1 parts by weight previously dissolved in vegetable glycol (propanediol), which is used in an amount of 1 to 3 parts by weight. The system is stirred on a mechanical stirrer at a speed of 300 to 700 rpm for 5 to 15 minutes, and then the pre-emulsion prepared in this way is homogenized using an ultrasonicator using the sonication amplitude from 69% to 89%, preferably the maximum sonication amplitude should not be exceed 79%, and the sonication power is from 20 - 60 W, preferably 40 W. The homogenization process is carried out for a period of 60 to 2400 s, preferably 180.
The prepared systems are combined using a mechanical stirrer with a constant rotational speed of 1500 rpm for 1-5 minutes, preferably 2 minutes at a temperature of 25°C. Then the resulting reaction mixture is placed in a refrigerator at a temperature
of 4-7 °C for 24 hours. After this time, the obtained product is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then the reaction mixture is transferred to a Petri dish, a cross-linking agent - component C is added and the proper ionic crosslinking reaction is carried out. The cross-linking agent is added to the reaction system in a 2: 1 weight ratio to the amount of the starting composition. The cross-linking agent is prepared by dissolving 5 parts by weight of anhydrous calcium chloride in 95 parts by weight of water (component C). The ionic cross-linking reaction is carried out for a period of 15-45 minutes, preferably 30 minutes, at a temperature of 22-25°C. The cross-linked hydrogel compositions are then washed with distilled water to remove residual cross-linking agent, yielding a final product that can be given any shape. The final shape of the final product results from its intended use and it is a compress for use on the skin.
The product may be in the form of a mask, which is a compress to be applied to the face.
In the solution according to the invention, the skeleton of the hydrogel matrix is made up of polysaccharides in the form of alginates from brown algae, which are biocompatible, biodegradable, non-toxic and safe to use.
Unlike gels, hydrogels are not absorbed from the surface of the skin, but leave a transparent layer on it that protects against external factors and microorganisms. They also have absorptive properties, so they can absorb exudate from wounds, accelerating the healing process and regenerating damaged tissues.
The hydrolates used in the production of the preparation according to the invention enable the skin to restore its proper, slightly acidic pH, thus protecting the skin against the harmful effects of external factors and maintaining its physiological microbiome. At the same time, the use of hydrolates for the production of a cosmetic product in the form of a hydrogel bio-mask has an impact on reducing water consumption in the cosmetics industry.
The silymarin used in the product according to the invention is an active complex of flavonolignans obtained from the seed shells of milk thistle (Silybum marianum). It is an effective antioxidant and anti-inflammatory agent. It has the ability to eliminate the harmful effects of UV radiation, reduces possible allergic reactions, swelling, erythema caused by this radiation, reduces DNA damage and inhibits the induction of apoptosis (cell death). It is recommended to use silymarin in case of
allergic problems and skin inflammations. There are research results showing the antiaging properties of silymarin in relation to skin cells, these properties result from the stimulating effect of silymarin on keratinocytes, which causes the synthesis of collagen and elastin. Due to the fact that this substance is characterized by very low solubility in both water and fats, thus limiting its bioavailability, which is a barrier to its use in cosmetic preparations, and thus.
The bakuchiol used in the preparation is a chemical compound called plant retinol due to its almost identical action, but without the side effects that apply to retinol and retinoid. Like retinol and retinoid, it has an exfoliating and normalizing effect, reduces wrinkles, furrows and helps to remove discoloration, normalizes sebum secretion, eliminates acne, rejuvenates and delays skin aging.
In addition, oils rich in γ-linolenic acid (GLA), which is a precursor of prostaglandin responsible for the proper condition of the skin, used in the preparation, show synergistic effects with the components of the solution according to the invention. Particularly valuable plant raw materials for obtaining oils rich in GLA are the seeds:
• borage s (Borago officinalis),’
• common evening primrose (Oenothera biennis) and evening primrose (Oenothera paradoxa),’
• hemp (Cannabis sativa),’
• viper's bugloss (Echium vulgare);
• black currant seeds (Ribes nigrum ;
The introduction of spirulina (blue-green algae) to the reaction mixture allows to obtain a product with better therapeutic properties. Spirulina has a very rich composition, because it comprises many active and nutritional substances, thanks to which it improves blood circulation, evens skin tone and is responsible for regulating the activity of sebaceous glands. In addition, it has an antioxidant effect, neutralizes harmful free radicals, thus protecting the skin against premature aging, it also has a soothing, anti-inflammatory and anti-allergic effect (inhibits the secretion of histamine).
The presence of nanodispersion in the hydrogel matrix of the preparation according to the invention increases the bioavailability of the lipophilic extract from milk thistle seeds - silymarin, and affects its stability and protects this component
against external factors, while extending its action to a much greater extent than conventional preparations (creams), where it is available on the market. In addition, this form of delivery of the lipophilic active ingredient ensures deeper skin penetration, which will enhance the effectiveness of the preparation. An additional advantage of the preparation is the introduction of nanoformulation into the hydrogel matrix, to which spirulina and hydrolate have previously been introduced. This combination of active ingredients increases the effectiveness of the preparation, regenerating and soothing, due to the content of many active substances with different properties. In addition, the nanocarrier/hydrogel matrix systems are characterized by controlled release, resulting in prolonged exposure of the skin to the active ingredient in the formulation of the invention. The nanoparticles of the internal phase of the nanoemulsion comprising the lipophilic active substance (silymarin) in the first stage of action are released into the hydrogel matrix, which is cross-linked, which means that the particles of the penetrating active substance are captured and slowly released by the cross-linked structure. In this way, the exposure of the skin to the lipophilic component is prolonged. This combination also allows to extend the contact time of the preparation with the skin and increases the degree of hydration of the skin by creating a hydrophilic film on its surface and limiting transepidermal water loss. This is a very important aspect in the process of skin regeneration. The hydrolates used in the preparation as a dispersing phase in the hydrogel matrix enhance the regenerating effect of spirulina and milk thistle extract, and additionally provide bacteriostatic, antiswelling, moisturizing, soothing and alleviating inflammatory effects on the skin.
EXAMPLES
The invention has been disclosed in the examples of embodiments and in the drawings, where Fig. 1 shows an exemplary appearance of a cosmetic preparation in the form of a hydrogel face mask, Fig. 2 shows other examples of a cosmetic preparation in the form of compresses of various sizes and with different content of component B, and Fig. 3 shows the morphology and the surface topography of the hydrogel mask of the invention by SEM analysis.
Example 1
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of
sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
Component (A): The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in lavender hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - polymer solution. Then, spirulina is dosed into the system in the amount of 1 part by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
Component (C): 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 1 :
To component (A) component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel
compositions are then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 2
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
Component (A): The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in lavender hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - polymer solution. Then, spirulina is dosed into the system in the amount of 1 part by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
Component (C): 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 2:
To component (A) component (B) is introduced in a weight ratio of 2: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a
mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel composition is then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 3
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
Component (A): The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in lavender hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - polymer solution. Then, spirulina is dosed into the system in the amount of 1 part by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained
pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
Component (C): 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 3 :
To component (A) component (B) is introduced in a weight ratio of 3: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 4
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; lavender hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
Component (A): The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in lavender hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - polymer solution. Then, spirulina is dosed into the system in the amount of 1 part by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of borage oil, 1 part by weight of bakuchiol and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
Component (C): 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 4:
To component (A) component (B) is introduced in a weight ratio of 1 : 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 5
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; eucalyptus hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company
Merck, bakuchiol - of company "Zrob sobie krem", borage oil - of company Provital, demineralized water.
Component (A): The sodium salt of alginic acid obtained from brown algae in the amount of 2.0 parts by weight is dissolved in eucalyptus hydrolate in the amount of 98.0 parts by weight, at the temperature of70-75°C - polymer solution. Then, spirulina is dosed into the system in the amount of 1 part by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 8 parts by weight of borage oil, and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase.
A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 600 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 89% and the sonication time of 120 s.
Component (C): 5 g CaCl2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask:
To component (A) component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish (Φ) 18,5cm), carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2:1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-
linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 6
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; neroli hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", hemp oil - Olvita, demineralized water, Dermosoft 1388 - Evonik Dr. Straetmans GmbH, sodium benzoate - Sigma Aldrich. Solution (A):
The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in neroli hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - polymer solution. Then, into the system they are dosed: spirulina in the amount of 0.5 part by weight relative to the polymer solution, a mixture of menthol and menthyl lactate (Corum 9230) in the amount 0.5 parts by weight relative to the polymer solution, Dermosoft 1388 in the amount 2 parts by weight and sodium benzoate in the amount 0.5 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 15 minutes, at a temperature of 20-25°C.
Component (B): 0.015 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of hemp oil, 1 part by weight of bakuchiol and 3 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase. A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 86 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 73 °C, then combined and dispersed using a mechanical stirrer for 15 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 69% and the sonication time of 180 s.
Component (C): 5 g CaCl2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 6:
To component (A) component (B) is introduced in a weight ratio of 3: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 7
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; cornflower hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", black currant seeds oil - Olvita, demineralized water, Dermosoft 1388 - Evonik Dr. Straetmans GmbH, sodium benzoate - Sigma Aldrich.
Solution (A):
The sodium salt of alginic acid obtained from brown algae in the amount of 1.5 parts by weight is dissolved in cornflower hydrolate in the amount of 98.5 parts by weight, at the temperature of 70-75°C - (polymer solution). Then, into the system they are dosed: spirulina in the amount of 1.5 part by weight relative to the polymer solution, a mixture of menthol and menthyl lactate (Corum 9230) in the amount 0.25 parts by weight relative to the polymer solution, Dermosoft 1388 in the amount 2 parts by weight and sodium benzoate in the amount 0.5 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 15 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of black currant seed oil, 1 part by weight of bakuchiol
and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase. A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
Component (C): 5 g CaCl2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 7:
To component (A) component (B) is introduced in a weight ratio of 1 : 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 8
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; linden flower hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", primrose oil - Olvita, demineralized water, Dermosoft 1388 - Evonik Dr. Straetmans GmbH
Solution (A):
The sodium salt of alginic acid obtained from brown algae in the amount of 2.5 parts by weight is dissolved in linden hydrolate in the amount of 97.5 parts by weight, at the temperature of 70-75°C - (polymer solution). Then, into the system they are dosed: spirulina in the amount of 1.0 part by weight relative to the polymer solution, Dermosoft 1388 in the amount 2 parts by weight and sodium benzoate in the amount 0.5 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 15 minutes, at a temperature of 20-25°C.
Component (B): 0.005 parts by weight of silymarin is dissolved in 2 parts by weight of propanediol. 8 parts by weight of primrose oil, and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase. A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 500 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 89% and the sonication time of 180 s.
Component (C): 5 g CaCl2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 8:
To component (A) component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-linking
agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 9
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; rose hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECOSPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", borage oil - Olvita, demineralized water.
Solution (A):
The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in rose hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - (polymer solution). Then, into the system they are dosed: spirulina in the amount of 0.5 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 15 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 12 parts by weight of borage oil, and 3 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase. A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 82 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 15 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 60 W, the amplitude of 89% and the sonication time of 240 s.
Component (C): 5 g CaCl2 are dissolved in 95 ml of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 9:
To component (A) component (B) is introduced in a weight ratio of 1 : 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for
24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
Example 10
Reagents: sodium salt of alginic acid from brown algae - medium viscosity - product of Sigma Aldrich Inc.; spirulina - sea algae - a product of the company "Zrob sobie krem"; calendula hydrolate - of company ECOSPA; anhydrous calcium chloride - a product of Avantor Performance Materials Poland S.A; Olivem 1000 (a mixture of sorbitan olivate and cetearyl olivate) - of company ECO SPA, silymarin - of company Merck, bakuchiol - "Zrob sobie krem", hemp oil - Olvita, demineralized water.
Solution (A):
The sodium salt of alginic acid obtained from brown algae in the amount of 3.5 parts by weight is dissolved in calendula hydrolate in the amount of 96.5 parts by weight, at the temperature of 70-75°C - (polymer solution). Then, into the system they are dosed: spirulina in the amount of 1.0 parts by weight relative to the polymer solution, under constant stirring on a mechanical stirrer at a constant speed of 1500 rpm, for 3 minutes, at a temperature of 20-25°C.
Component (B): 0.01 parts by weight of silymarin is dissolved in 3 parts by weight of propanediol. 7 parts by weight of hemp oil, 1 part of bakuchiol, and 2 parts by weight of O/W emulsifier (a mixture of sorbitan olivate and cetearyl olivate) are weighed, which constitute the oil phase. A solution of silymarin in propanediol is added to the oil phase thus prepared. The ingredients of the aqueous phase (water) are then weighed in an amount of 87 parts by weight. In order to obtain a pre-emulsion, a certain amount of the oil phase and the water phase are heated to 70°C, then combined and dispersed using a mechanical stirrer for 10 minutes, using the stirrer's rotational speed v = 700 rpm. The obtained pre-emulsion is subjected to the homogenization process using an ultrasonicator with a probe, using the sonication power of 40 W, the amplitude of 79% and the sonication time of 180 s.
Component (C): 5 parts by weight of anhydrous calcium chloride is dissolved in 95 parts by weight of distilled water at a temperature of 20-25°C.
The course of the reaction for obtaining the hydrogel bio-mask No. 9:
To component (A) component (B) is introduced in a weight ratio of 4: 1, maintaining a total weight of the reaction mixture of 30 g, while continuously stirring on a mechanical stirrer at a constant speed of 1500 rpm for 2 minutes at a temperature of 22-25°C. Then the resulting reaction mixture is placed at a temperature of 4 -7°C for 24h. After this time, it is gradually heated to the temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1 minute. Then, it is transferred to a Petri dish, carrying out the proper ionic cross-linking reaction using a cross-linking agent (component (C)) in a weight ratio of 2: 1 to the amount of the reaction mixture to be cross-linked. The ionic cross-linking reaction is carried out for 30 minutes at a temperature of 22 -25°C. The cross-linked hydrogel compositions are then washed with distilled water to rinse off residual cross-linking agent. As the final product, a flexible hydrogel bio-mask was obtained, which can be used as a compress on the skin.
The obtained components and products were tested.
Chart No. 1 shows the effect of spirulina addition and nanodispersion on the viscosity of alginate systems before the actual crosslinking reaction
Chart No. 1
For cosmetic or dermatological applications, in which hydrogels are applied primarily to the surface of the skin, the produced hydrogel must have the right consistency. Too soft consistency will cause the hydrogel to flow off after application, while too hard will make it difficult to spread it on the skin surface. Chart 1 presents the viscosity results for the systems that were used to obtain the bio-mask in Example 4. The highest viscosity is shown by a solution of sodium salt of alginic acid (12,032 mPas), but the addition of spirulina (component A) and nanodispersion (component B) forming a mixture reaction (bio-mask before ion cross-linking) significantly reduced its viscosity (to 6,318 mPas, which was the aim, because it is a value close to the reference composition (6,796 mPas), i.e. a sample obtained on the basis of literature data.
Chart 2 shows the Shore C hardness results for selected products - hydrogel bio-masks from examples 1-4.
Chart No. 2
Chart 2 presents the hardness results for the reference sample, which is a hydrogel matrix containing spirulina in the amount described in examples 1-4 (component A), but without the addition of nanodispersions (component B), and biomasks with different amounts of nanodispersions. As you can see, the introduction of nanodispersion slightly reduces the hardness of the final products even to 46.7 °Sh C (Example 4), but all of them can be classified as soft materials.
Based on the obtained SEM microphotographs, it can be concluded that the structure of the product in the form of a hydrogel bio-mask is highly porous, which enables proper oxygen permeability and positively affects the release of active substances.
Claims
Patent claims A composition characterized in that it comprises: a component A and component B combined in a weight ratio of 4: 1 to 1 : 1, where the component A is: a polymer solution, which is from 0.5 to 5 parts by weight of sodium salt of alginic acid from brown algae and from 95 to 99.5 parts by weight of a hydrolate with bacteriostatic and antiseptic properties and/or anti-swelling properties and/or moisturizing, soothing and alleviating properties, and from 0.33 to 1.65 parts by weight of spirulina relative to the polymer solution, from 0 to 1.2 parts by weight of a mixture of menthol and menthyl lactate relative to the polymer solution, from 0 to 2.5 parts by weight of a preservative relative to the polymer solution, preferably benzoate sodium, and the component B an O/W nanodispersion is: from 85 to 95 parts by weight of water phase, from 4 to 12 parts by weight of the liquid lipid of oil phase, from 1 to 3 parts by weight of the stabilizer mixture of sorbitan olivate and cetearyl olivate, in which sorbitan olivate from 30 to 50%, and cetearyl olivate from 50 to 70%, from 1 to 3 parts by weight of vegetable glycol, propanediol, from 0.005 to 0.1 parts by weight of the lipophilic active ingredient, silymarin, from 0.5 to 2 parts by weight of bakuchiol. The composition according to claim 1, characterized in that the hydrolate with bacteriostatic and antiseptic properties is lavender hydrolate, or juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate. The composition according to claim 1, characterized in that the hydrolate with anti-swelling properties is cornflower hydrolate. The composition according to claim 1, characterized in that the hydrolate with moisturizing, soothing and alleviating properties is linden flower hydrolate, or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate. The composition according to claim 1, characterized in that the liquid lipid of oil phase is borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum).
Use of the composition according to any one of claims 1-5 for manufacturing of cosmetic and cosmetic-therapeutic products for topical application with moisturizing, alleviating, regenerating, soothing, anti-swelling and anti-aging effect. The use according to claim 6, characterized in that the cosmetic and/or cosmetic- therapeutic product is chosen from the group of hydrogel compresses comprising active ingredients, preferably in the form of a hydrogel bio-mask. A cosmetic product a hydrogel bio-mask in the form of a compress, in the form of a hydrogel material of natural origin and natural active ingredients, characterized in that it is a combination of a hydrogel matrix obtained from ionically cross-linked alginates from brown algae in a hydrolate environment with bacteriostatic and antiseptic properties and/or a hydrolate with anti-swelling properties and/or a hydrolate with moisturizing, soothing and alleviating properties as well as active and supportive ingredients (component A) and O/W type nanodispersion (component B) based on oils rich in y-linolenic acid (GLA) comprising a lipophilic active ingredient, wherein component A and component B are combined in a weight ratio of from 4: 1 to 1 : 1. The cosmetic product according to claim 8, characterized in that the component A, and thus the hydrogel matrix comprises spirulina as an active ingredient and/or a mixture of menthol and menthyl lactate as an ingredient with cooling properties. The cosmetic product according to claim 8, characterized in that the nanodispersion comprises silymarin and bakuchiol as lipophilic active ingredients. The cosmetic product according to claim 8, characterized in that the hydrogel matrix comprises preferably lavender hydrolate, or juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate, as a hydrolate of with bacteriostatic and antiseptic properties. The cosmetic product according to claim 8, characterized in that the hydrogel matrix comprises preferably cornflower hydrolate as hydrolate with antiswelling properties. The cosmetic product according to claim 8, characterized in that the hydrogel matrix comprises preferably linden flower hydrolate, or rose hydrolate, or
chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate. as a hydrolate with moisturizing, soothing and alleviating skin inflammation properties. The cosmetic product according to claim 8, characterized in that the O/W type nanodispersion (component B) comprises water phase, which constitutes from 85 to 95 parts by weight, the liquid lipid of oil phase which is oil rich in y- linolenic acid (GLA) in the amount of from 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in the amount from 1 to 3 parts by weight, vegetable glycol, preferably propanediol in the amount from 1 to 3 parts by weight, and a lipophilic active ingredient, which is silymarin in the amount from 0.005 to 0.1 parts by weight and/or bakuchiol in the amount from 0.5 to 2 parts by weight. The cosmetic product according to claim 14, characterized in that the O/W type nanodispersion (component B) comprises the active ingredient - silymarin, dissolved in the vegetable glycol, preferably dissolved in propanediol The cosmetic product according to claim 14, characterized in that as the liquid lipid of oil phase it comprises borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum). A method of manufacturing the hydrogel bio-mask based on the natural polymer alginate from brown algae enriched in active substances closed in the form of nanoemulsion, in which method a natural polymer solution is prepared, a component in the form of nanoemulsion comprising an active ingredient is prepared, a cross-linking solution is prepared, and then all components are mixed, characterized in that the aqueous solution of sodium alginate is prepared by dissolving sodium salt of alginic acid from brown algae in a hydrolate with bacteriostatic and antiseptic properties, preferably in lavender hydrolate, and/or in a hydrolate with anti-swelling properties and/or in a hydrolate with moisturizing, soothing and alleviating properties, in at a temperature from 70 to 75°C, then the polymer solution is cooled to ambient temperature and is combined with continuous stirring with spirulina in an amount of 0.33 to 1.65 parts by weight relative to the polymer solution, preferably in an amount of 1 part by weight, is still stirred for 3 to 5 minutes, then to the reaction system is
introduced from 0.0 to 1.2 parts by weight of a mixture of menthol and menthyl lactate relative to the polymer solution, from 0 to 2 parts by weight of a mixture of sorbitan olivate and cetearyl olivate relative on the polymer solution, from 0 to 0.5 parts by weight of sodium benzoate relative to the polymer solution and is still stirred for a period of 5 to 15 minutes (component A), then, into the reaction system an O/W type nanodispersion - (component B) is introduced, where the component B comprises a water phase, which constitutes from 85 to 95 parts by weight, a liquid lipid of the oil phase, which is an oil rich in y-linolenic acid (GLA) in an amount of 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in an amount of 1 to 3 parts by weight, vegetable glycol, preferably propanediol in an amount of 1 to 3 parts by weight and a lipophilic active ingredient which is silymarin in an amount of 0.005 to 0.1 part by weight and/or bakuchiol in an amount of 0.5 - 2 parts by weight, the reaction mixture is stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm for 1-5 minutes, preferably for a period of 2 minutes while maintaining the temperature of the reaction environment at 25°C, then the resulting reaction mixture is placed at a temperature of 4-7°C for 24 hours, after this time, the obtained product is gradually heated to a temperature of 22-25°C, and then stirred with a mechanical stirrer at a constant rotational speed of 1500 rpm min for 1 minute, then into the reaction system the crosslinking agent is introduced in a volume ratio of 2: 1 relative to the reaction mixture, which comprises 5 parts by weight of anhydrous calcium chloride in 95 parts by weight of distilled water (component C), the composition is crosslinked at a temperature of 20 - 25°C for a period of 15 to 45 minutes, preferably 30 minutes, then the obtained product is washed with water. The method according to claim 17, characterized in that the component A and component B are combined in a weight ratio of 4: 1 to 1 : 1. The method according to claim 17, characterized in that the aqueous solution of sodium alginate - polymer solution - is prepared by dissolving from 0.5 to 5 parts by weight, preferably 3.5 parts by weight, of the sodium salt of alginic acid from brown algae in the hydrolate in an amount of 95 to 99.5 parts by weight, preferably 96.5 parts by weight. The method according to claim 17, characterized in that a hydrolate with bacteriostatic and antiseptic properties was used as a dispersing agent for the
preparation of the sodium alginate solution, preferably juniper hydrolate, or eucalyptus hydrolate, or neroli hydrolate, or calendula hydrolate, or tea tree hydrolate, or peppermint hydrolate, or witch hazel hydrolate. The method of manufacturing a hydrogel bio-mask according to claim 17, characterized in that a hydrolate with anti-swellins properties, preferably cornflower hydrolate, was used as a dispersing agent for the preparation of the sodium alginate solution. The method according to claim 17, characterized in that as a dispersing agent for the preparation of the sodium alginate solution, a hydrolate with moisturizing, soothing and alleviating skin inflammation properties was used, preferably linden flower hydrolate or rose hydrolate, or chamomile hydrolate, or calendula hydrolate, or linden hydrolate, or fig opuntia hydrolate. The method according to claim 17, characterized in that as the component B - an O/W nanodispersion is used, which comprises the water phase, which constitutes from 85 to 95 parts by weight, the liquid lipid of the oil phase, which is oil rich in y-linolenic acid (GLA) in an amount from 4 to 12 parts by weight, a stabilizer which is a mixture of sorbitan olivate and cetearyl olivate in an amount of 1 to 3 parts by weight, vegetable glycol, preferably propanediol in an amount of 1 to 3 parts by weight, and an active ingredient which is silymarin in an amount of 0.005 to 0.1 part weight and/or bakuchiol in an amount of 0.5 - 2 parts by weight. The method according to claim 17, characterized in that borage seed oil Borago officinalis) and/or common evening primrose (Oenothera biennis) and/or evening primrose (Oenothera paradoxa) and/or hemp (Cannabis sativa) and/or viper's bugloss (Echium vulgare) and/or black currant seeds (Ribes nigrum) is used as the liquid lipid of oil phase. The method according to claim 17, characterized in that divalent ions, preferably Ca2+, are used as the cross-linking agent. The method according to claim 24, characterized in that Ca2+ ions come from a calcium salt solution, such as a calcium chloride solution.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL440805A PL440805A1 (en) | 2022-03-30 | 2022-03-30 | Composition, use of the composition, cosmetic preparation bio-hydrogel mask in the form of a poultice, preparation method |
PLP.440805 | 2022-03-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023187632A1 true WO2023187632A1 (en) | 2023-10-05 |
Family
ID=86332333
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2023/053056 WO2023187632A1 (en) | 2022-03-30 | 2023-03-28 | Composition, application of the composition, cosmetic preparation hydrogel bio-mask in the form of a compress, method of manufacturing the preparation |
Country Status (2)
Country | Link |
---|---|
PL (1) | PL440805A1 (en) |
WO (1) | WO2023187632A1 (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101012289B1 (en) * | 2010-08-07 | 2011-02-10 | 성 준 유 | Sheetless face mask using hydrogel and fabrication method thereof |
EP2772270A1 (en) * | 2011-10-11 | 2014-09-03 | Genic Co., Ltd. | Emulsified hydrogel composition and a production method therefor |
CN111743850A (en) * | 2020-08-13 | 2020-10-09 | 环科创建有限公司 | Edible ampelopsis grossedentata hydrogel mask and preparation method thereof |
WO2021040233A1 (en) * | 2019-08-30 | 2021-03-04 | 코스맥스 주식회사 | Cosmetic composition comprising calamine dispersed in biopolymer, and sheet mask using same |
-
2022
- 2022-03-30 PL PL440805A patent/PL440805A1/en unknown
-
2023
- 2023-03-28 WO PCT/IB2023/053056 patent/WO2023187632A1/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101012289B1 (en) * | 2010-08-07 | 2011-02-10 | 성 준 유 | Sheetless face mask using hydrogel and fabrication method thereof |
EP2772270A1 (en) * | 2011-10-11 | 2014-09-03 | Genic Co., Ltd. | Emulsified hydrogel composition and a production method therefor |
WO2021040233A1 (en) * | 2019-08-30 | 2021-03-04 | 코스맥스 주식회사 | Cosmetic composition comprising calamine dispersed in biopolymer, and sheet mask using same |
CN111743850A (en) * | 2020-08-13 | 2020-10-09 | 环科创建有限公司 | Edible ampelopsis grossedentata hydrogel mask and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
PL440805A1 (en) | 2023-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5615717B2 (en) | Chitosan gel for dermatological use, its production method and use | |
CN106822988B (en) | Alginate fiber functional dressing and application thereof, and alginate fiber functional dressing patch | |
KR101221734B1 (en) | Cosmetic composition of multi-pore patch for skin improvement of two-form type using lyophilization | |
KR102394532B1 (en) | Cosmetic composition containing hyaluronic acids having different molecular weight | |
WO2011157880A1 (en) | Antioxidant composition | |
EP2739276B1 (en) | Antiseptic composition | |
CA2425780C (en) | Composition with a base of a therapeutically active compound, in particular honey, for the treatment of wounds | |
Khorasani et al. | The effects of Aloe Vera cream on split-thickness skin graft donor site management: a randomized, blinded, placebo-controlled study | |
CN109820824B (en) | Capsaicin liquid crystal nano spray preparation for promoting skin wound healing and preparation method thereof | |
US20140348873A1 (en) | Urea-Silicone Gel for Hyperkeratosis Treatment | |
RU2699362C2 (en) | Composition based on cerium dioxide nanoparticles and brown algae polysaccharides for treating wounds | |
WO2014190179A2 (en) | Urea silicon gel for scars and hydration treatment and method of using same | |
CN109662942A (en) | A kind of antibacterial temperature sensitive type gel preparation and preparation method thereof | |
ES2590978T3 (en) | Biocompatible injectable products with zinc and / or saccharide salt release in the form of zinc and its uses | |
WO2023187632A1 (en) | Composition, application of the composition, cosmetic preparation hydrogel bio-mask in the form of a compress, method of manufacturing the preparation | |
US20020037319A1 (en) | Drug preparations | |
CN108403637A (en) | A kind of mouthspray preparation and preparation method thereof | |
Kumar et al. | Marine biopolymers for transdermal drug delivery | |
KR20200141214A (en) | Hydrogel composition, preparing method for hydrogel composition and cosmetic composition including the same | |
Almoshari | Novel Hydrogels for Topical Applications: An Updated Comprehensive Review Based on Source. Gels 2022, 8, 174 | |
Poorahmary Kermany | Carbopol hydrogels for topical administration: treatment of wounds | |
RU2694372C1 (en) | Haemostatic agent based on chitosan succinate and calendula extract | |
CN114177301B (en) | Composition containing tranexamic acid and application of composition in preparation of medicines for treating chloasma | |
JP2010241780A (en) | Method for producing high concentration fibroin gel | |
KR20220080376A (en) | Cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23723253 Country of ref document: EP Kind code of ref document: A1 |